August 2026
1. BORKAR DS, Ford CB, Song A, Lusk JB, et al
   Neighborhood Socioeconomic Deprivation and Adherence to Diabetic Retinopathy Screening Guidelines.
   Am J Ophthalmol. 2026 Aug 5:S0002-9394(26)00429.
   

   >> Share

   
   
2. TRAN J, Chhablani J
   Unsuccessful Clinical Trials in Retina: Lessons Learned.
   Am J Ophthalmol. 2026;288:284-294.
   

   >> Share

   
   July 2026
3. ALHELALY M, Abbasgholizadeh R, Chung YC, Habibi A, et al
   Comparison of Retinal Nonperfusion in Diabetic Macular Edema Treated with Brolucizumab Versus Aflibercept: A KINGFISHER Trial Analysis.
   Am J Ophthalmol. 2026 Jul 23:S0002-9394(26)00419.
   

   >> Share

   
   
4. KAKIHARA S, Shah J, Zhuang K, Fawzi AA, et al
   Hyperreflective Abnormal Areas in the Middle Retinal Layers on En Face OCT for Diagnostic Discrimination in Diabetic Eyes.
   Am J Ophthalmol. 2026 Jul 13:S0002-9394(26)00381.
   

   >> Share

   
   
5. KIM SB, Zhou MY, Allan KC, Kaelber DC, et al
   Evaluation of the impact of gamma-aminobutyric acid on diabetic retinopathy in a large US population-based cohort.
   Am J Ophthalmol. 2026 Jul 11:S0002-9394(26)00385.
   

   >> Share

   
   June 2026
6. ZHOU C, Shen Y, Li S, Li Y, et al
   Therapeutic response to anti-VEGF retreatment among eyes with stabilized vision after being lost to follow-up in diabetic macular edema: A nationwide, registry-based cohort study.
   Am J Ophthalmol. 2026 Jun 22:S0002-9394(26)00341.
   

   >> Share

   
   May 2026
7. WANG LU
   Comment on "Macular OCTA Biomarkers Predict Regional Retinal Nonperfusion Patterns on Ultra-Widefield Angiography in Diabetes".
   Am J Ophthalmol. 2026 May 25:S0002-9394(26)00282.
   

   >> Share

   
   
8. KAKIHARA S, Fawzi AA
   Reply to Comment on "Macular OCTA Biomarkers Predict Regional Retinal Nonperfusion Patterns on Ultra-Widefield Angiography in Diabetes".
   Am J Ophthalmol. 2026 May 23:S0002-9394(26)00283.
   

   >> Share

   
   
9. KRZYWICKI T, Engin CD, Grzybowski A
   AUTO MACHINE LEARNING FOR DIABETIC RETINOPATHY SCREENING: A HEAD-TO-HEAD MULTI-PLATFORM COMPARISON AGAINST HUMAN GRADERS AND IDX-DR.
   Am J Ophthalmol. 2026 May 2:S0002-9394(26)00227.
   

   >> Share

   
   April 2026
10. SHAH J, Makwana B, Panchal K, Patel V, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy.
    Am J Ophthalmol. 2026 Apr 21:S0002-9394(26)00219.
    

    >> Share

    
    
11. GUMUSTOP SS, Ding X, Zhang YS, Ploumi I, et al
    Assessing Retinal Non-Perfusion with Ultra-Widefield OCT-A: Correlations with Diabetic Retinopathy Severity and Peripheral Lesions.
    Am J Ophthalmol. 2026 Apr 10:S0002-9394(26)00199.
    

    >> Share

    
    March 2026
12. KAKIHARA S, Busza AM, Duffy BV, Zhuang K, et al
    Macular OCTA Biomarkers Predict Regional Retinal Nonperfusion Patterns on Ultra-Widefield Angiography in Diabetes.
    Am J Ophthalmol. 2026 Mar 28:S0002-9394(26)00161.
    

    >> Share

    
    
13. GARG I, Duich M, Uwakwe C, Wai KM, et al
    Swept-Source OCT Angiography Vascular Metrics as Biomarkers for Renal Function in Patients with Diabetes Mellitus.
    Am J Ophthalmol. 2026 Mar 17:S0002-9394(26)00136.
    

    >> Share

    
    
14. ABDELAAL A, Serhan HA, Alsaadi M, AbouJabal K, et al
    Metformin Use and Risk of Glaucoma: A Systematic Review and Meta-analysis.
    Am J Ophthalmol. 2026 Mar 9:S0002-9394(26)00129.
    

    >> Share

    
    
15. WU AL, Hao J, Gao L, Guo Y, et al
    Elevated Retinal Neovascularization on Widefield Optical Coherence Tomography Angiography Predicts Complications in High-Risk Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2026;283:268-278.
    

    >> Share

    
    February 2026
16. KHANGURA MS, Spratt MA, Gao A, Manhapra A, et al
    The Association Between Diabetic Retinopathy Severity and Dementia Risk: A TriNetX Longitudinal Cohort Study.
    Am J Ophthalmol. 2026 Feb 13:S0002-9394(26)00073.
    

    >> Share

    
    
17. MURRAY M, Schifano F, Chiappini S, Corkery JM, et al
    Reply to comment on: "Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists: an examination of the FAERS database" (Am J Ophthalmol. 2025 Dec 20;S0002-9394(25)00666-X).
    Am J Ophthalmol. 2026 Feb 10:S0002-9394(26)00062.
    

    >> Share

    
    
18. SANCHEZ VMA
    Comment on: Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS database.
    Am J Ophthalmol. 2026 Feb 9:S0002-9394(26)00061.
    

    >> Share

    
    
19. ZHOU J, Lee DA, Talebi Y, Wu G, et al
    Risk of Dementia in Type 2 Diabetes Patients with Open-Angle Glaucoma: Insights from a Nationwide Real-World Cohort Study.
    Am J Ophthalmol. 2026 Feb 7:S0002-9394(26)00060.
    

    >> Share

    
    January 2026
20. VIGGIANO P, Carra A, Bruno G, Boscia G, et al
    Microaneurysm Reflectivity as a prognostic biomarker for intravitreal Treatment Response in Diabetic Retinopathy.
    Am J Ophthalmol. 2026 Jan 28:S0002-9394(26)00043.
    

    >> Share

    
    
21. HE L, Guo X, Yong Z, Zha Y, et al
    Reply to Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
    Am J Ophthalmol. 2026 Jan 20:S0002-9394(26)00022.
    

    >> Share

    
    
22. KAKIHARA S, Fawzi AA
    Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-Pan-Retinal Photocoagulation.
    Am J Ophthalmol. 2026 Jan 14:S0002-9394(26)00021.
    

    >> Share

    
    December 2025
23. LIN BH, Chuang SH, Wu LC, Chen YP, et al
    Association of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists with Risk of Cataract.
    Am J Ophthalmol. 2025 Dec 26:S0002-9394(25)00687.
    

    >> Share

    
    
24. MURRAY M, Schifano F, Chiappini S, Corkery JM, et al
    Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database.
    Am J Ophthalmol. 2025 Dec 20:S0002-9394(25)00666.
    

    >> Share

    
    
25. HONG AT, Lin F, Baxter S, Weinreb RN, et al
    Tirzepatide is Associated with Reduced Risk of Primary Open-Angle Glaucoma and Ocular Hypertension in Patients with Type 2 Diabetes.
    Am J Ophthalmol. 2025 Dec 6:S0002-9394(25)00653.
    

    >> Share

    
    November 2025
26. ANOZIE CC JR, Cox VF, Wiseman MT Jr, Lewis JE, et al
    Racial and ethnic disparities in risk for adverse ocular events in patients with diabetic retinopathy.
    Am J Ophthalmol. 2025 Nov 12:S0002-9394(25)00593.
    

    >> Share

    
    
27. HE L, Guo X, Yong Z, Zha Y, et al
    Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
    Am J Ophthalmol. 2025 Nov 9:S0002-9394(25)00587.
    

    >> Share

    
    October 2025
28. AHUJA AS, Paredes AA 3rd, Ahuja SA, Young BK, et al
    Glucagon-like Peptide-1 Receptor Agonist Use and Risk of Cataract Development.
    Am J Ophthalmol. 2025 Oct 21:S0002-9394(25)00558.
    

    >> Share

    
    
29. WANG TW, Luo WT, Tu YK, Chou YB, et al
    Diagnostic Accuracy of EyeArt for Fundus-Based Detection of Diabetic Retinopathy: A Systematic Review and Meta-analysis.
    Am J Ophthalmol. 2025 Oct 4:S0002-9394(25)00528.
    

    >> Share

    
    September 2025
30. FAN Y, Li L, Wu X, Yan Y, et al
    Longitudinal neural and microvascular changes in type 2 diabetic patients without retinopathy: a 2-year prospective cohort study.
    Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00503.
    

    >> Share

    
    
31. PAN SY, Weng CH, Tsai SF, Sheen YJ, et al
    Comparative Risk of Glaucoma in Patients Using Sodium-glucose Cotransporter-2 Inhibitors and Metformin: A Multinational Cohort Study.
    Am J Ophthalmol. 2025 Sep 19:S0002-9394(25)00504.
    

    >> Share

    
    August 2025
32. HUSSAIN ZS, Chauhan MZ, Muayad J, Loya A, et al
    Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration.
    Am J Ophthalmol. 2025 Aug 17:S0002-9394(25)00430.
    

    >> Share

    
    July 2025
33. PRASAD M, Agron E, Vitale S, Arunachalam T, et al
    Diabetic retinopathy incidence, progression, and health-related quality of life from the ACCORD trial.
    Am J Ophthalmol. 2025 Jul 23:S0002-9394(25)00371.
    

    >> Share

    
    June 2025
34. NWANYANWU K, Andoh J, Chen E, Xu Y, et al
    Social Determinants Associated with Diabetic Retinopathy Awareness: National Health and Nutrition Examination Survey (2005-2008).
    Am J Ophthalmol. 2025 Jun 21:S0002-9394(25)00330.
    

    >> Share

    
    May 2025
35. PARK KS, Kim JT, Lee MW
    Macular Microvasculature Asymmetry Analysis for Evaluating Open-Angle Glaucoma in Diabetic Retinopathy Patients Treated with Pan-Retinal Photocoagulation.
    Am J Ophthalmol. 2025 May 23:S0002-9394(25)00248.
    

    >> Share

    
    
36. LAKHANI M, Kwan AT, Mihalache A, Popovic MM, et al
    Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 Countries.
    Am J Ophthalmol. 2025 May 16:S0002-9394(25)00239.
    

    >> Share

    
    
37. HUSSAIN ZS, Shakarchi AF, Chauhan MZ, Jester DA, et al
    Is There a Safe Glycemic Threshold for Cataract Surgery?
    Am J Ophthalmol. 2025 May 3:S0002-9394(25)00221.
    

    >> Share

    
    March 2025
38. LIANG F, Tao S, Zhang Y, Liu S, et al
    Correlation between length of interdigitation zone with severity and progression of diabetic retinopathy.
    Am J Ophthalmol. 2025 Mar 27:S0002-9394(25)00152.
    

    >> Share

    
    
39. WANG Z, Yu Y, Ye Y, Wang L, et al
    Associations between Ambient Air Pollution and Five Common Vision-threatening Ocular Diseases in Middle-aged and Older Adults: A Large Prospective Cohort Study.
    Am J Ophthalmol. 2025 Mar 6:S0002-9394(25)00121.
    

    >> Share

    
    February 2025
40. LI M, He J, VanderBeek BL, Ying GS, et al
    Racial and Ethnic Disparities at Enrollment in DRCRnet Clinical Trials for Diabetic Macular Edema.
    Am J Ophthalmol. 2025 Feb 26:S0002-9394(25)00095.
    

    >> Share

    
    
41. JANMOHAMED IK, Salam MAU, Jamall O, Elgharably M, et al
    Faricimab-Associated Intraocular Inflammation with Features of Herpes Simplex Virus.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00096.
    

    >> Share

    
    
42. ABBASS NJ, Nahlawi R, Shaia JK, Allan KC, et al
    The Effect of Semaglutide and GLP-1 RAs on Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy.
    Am J Ophthalmol. 2025 Feb 25:S0002-9394(25)00094.
    

    >> Share

    
    
43. KHAN Z, Gaidhane AM, Singh M, Ganesan S, et al
    Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00081.
    

    >> Share

    
    
44. MAGRATH G, Luvisi J, Russakoff D, Oakley J, et al
    Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study.
    Am J Ophthalmol. 2025 Feb 20:S0002-9394(25)00073.
    

    >> Share

    
    
45. ANGUITA R, Desideri LF, Sivaprasad S, Wickham L, et al
    Reply to "Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2025 Feb 6:S0002-9394(25)00050.
    

    >> Share

    
    
46. UZUN S, Blair MP
    Comment on: Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2025 Feb 5:S0002-9394(25)00049.
    

    >> Share

    
    January 2025
47. TAKKAR B, Ketkar MR, Narula R, Tyagi M, et al
    A pilot randomized controlled trial evaluating haemostasis with fibrin glue during surgery for proliferative diabetic retinopathy.
    Am J Ophthalmol. 2025 Jan 28:S0002-9394(25)00040.
    

    >> Share

    
    December 2024
48. HUANG RS, Balas M, Jhaveri A, Popovic MM, et al
    Comparison of Renal Adverse Events Between Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Meta-Analysis.
    Am J Ophthalmol. 2024 Dec 31:S0002-9394(24)00590.
    

    >> Share

    
    
49. AMARAL DC, Guedes J, Cruz MRB, Cheidde L, et al
    GLP-1 RECEPTOR AGONISTS USE AND INCIDENCE OF GLAUCOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS: GLP-1 receptor agonists use and incidence of glaucoma.
    Am J Ophthalmol. 2024 Dec 26:S0002-9394(24)00589.
    

    >> Share

    
    
50. ANGUITA R, Desideri LF, Sivaprasad S, Wickam L, et al
    Reply to Comment on "Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy".
    Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00573.
    

    >> Share

    
    
51. NISHIDA K, Maeno T, Nishida K
    Comment on, Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Dec 17:S0002-9394(24)00572.
    

    >> Share

    
    November 2024
52. MOU K, Zhang M
    Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00546.
    

    >> Share

    
    
53. LIU K, Li T, Zhong P, Zhu Z, et al
    Reply to Comment on "Retinal and Choroidal Phenotypes Across Novel Subtypes of Type 2 Diabetes Mellitus".
    Am J Ophthalmol. 2024 Nov 28:S0002-9394(24)00547.
    

    >> Share

    
    
54. ZAMAN M, Zajner C, Xie J, Patil NS, et al
    Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis.
    Am J Ophthalmol. 2024 Nov 16:S0002-9394(24)00524.
    

    >> Share

    
    
55. ENG K, Zebardast N, Boland MV, Lo JE, et al
    Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes.
    Am J Ophthalmol. 2024 Nov 6:S0002-9394(24)00506.
    

    >> Share

    
    October 2024
56. ANGUITA R, Ferro Desideri L, Schwember P, Shah N, et al
    Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 27:S0002-9394(24)00488.
    

    >> Share

    
    
57. DING X, Romano F, Garg I, Gan J, et al
    Expanded Field OCT Angiography Biomarkers for Predicting Clinically Significant Outcomes in Non-Proliferative Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Oct 25:S0002-9394(24)00485.
    

    >> Share

    
    September 2024
58. KIM A, Ding X, Miller JB
    Ultra-widefield Swept-Source OCT Angiography vs. Ultra-widefield Fluorescein Angiography in Diabetic Retinopathy.
    Am J Ophthalmol. 2024 Sep 17:S0002-9394(24)00419.
    

    >> Share

    
    
59. TSAI WS, Thottarath S, Gurudas S, Pearce E, et al
    A Comparison of Optical Coherence Tomography Angiography Metrics and Artifacts on Scans of Different Sizes in Diabetic Macular Ischemia: The effect of different size scans on DMI evaluation.
    Am J Ophthalmol. 2024 Sep 13:S0002-9394(24)00433.
    

    >> Share

    
    
60. LUM F
    Comment on Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Study.
    Am J Ophthalmol. 2024 Sep 6:S0002-9394(24)00406.
    

    >> Share

    
    
61. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Reply to comment on: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Sep 4:S0002-9394(24)00407.
    

    >> Share

    
    
62. LIU K, Li T, Zhong P, Zhu Z, et al
    Longitudinal changes in retina and choroid across novel subtypes of diabetes mellitus: Subtypes of diabetes and retinal neurovascular changes.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00405.
    

    >> Share

    
    
63. HALLAJ S, Halfpenny W, Chuter BG, Weinreb RN, et al
    Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00392.
    

    >> Share

    
    August 2024
64. LEE MY, Han K, Min KH, Yu DS, et al
    Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study.
    Am J Ophthalmol. 2024 Aug 30:S0002-9394(24)00395.
    

    >> Share

    
    
65. LEE SH, Tseng BY, Wu MC, Wang JH, et al
    Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis.
    Am J Ophthalmol. 2024 Aug 21:S0002-9394(24)00379.
    

    >> Share

    
    July 2024
66. RAHMATI M, Smith L, Boyer L, Fond G, et al
    Factors affecting global adherence for the uptake of diabetic retinopathy screening: A systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 31:S0002-9394(24)00335.
    

    >> Share

    
    
67. RAHIMY E, Koo EB, Wai KM, Ludwig CA, et al
    Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications.
    Am J Ophthalmol. 2024 Jul 30:S0002-9394(24)00323.
    

    >> Share

    
    
68. BANTOUNOU MA, Nahar TAK, Plascevic J, Kumar N, et al
    Drug exposure as a predictor in diabetic retinopathy risk prediction models; a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Jul 19:S0002-9394(24)00313.
    

    >> Share

    
    June 2024
69. ARRUDA MP, Lima RV, Hira S, Moreira JLML, et al
    A Comprehensive Meta-Analysis on the Role of Analgesics and Anti-Inflammatories in Pan-retinal Photocoagulation.
    Am J Ophthalmol. 2024 Jun 26:S0002-9394(24)00264.
    

    >> Share

    
    May 2024
70. LI G, Sommi A, Klawe J, Ahmad S, et al
    Demographic and Systemic Risk Factors for Persistent Corneal Edema Following Cataract Surgery in Patients With and Without Diabetes.
    Am J Ophthalmol. 2024 May 25:S0002-9394(24)00228.
    

    >> Share

    
    
71. LIU X, Chang Y, Li Y, Liu Y, et al
    Association Between Cardiovascular Health and Retinopathy in US Adults: From NHANES 2005-2008.
    Am J Ophthalmol. 2024 May 16:S0002-9394(24)00223.
    

    >> Share

    
    
72. YILMAZ YC, Hayat SC, Ipek SC
    Corrigendum to Yilmaz YC, Hayat SC, Ipek SC. 'Analysis of Corneal and Lens Densitometry Changes in Patients With Type 1 Diabetes Mellitus' Am J Ophthalmol. 2023 Oct;254:23-30.
    Am J Ophthalmol. 2024 May 10:S0002-9394(24)00147.
    

    >> Share

    
    
73. VOICHANSKI S, Bousquet E, Abraham N, Santina A, et al
    En Face Optical Coherence Tomography Illustrates the Trizonal Distribution of Drusen and Subretinal Drusenoid Deposits in the Macula.
    Am J Ophthalmol. 2024;261:187-198.
    

    >> Share

    
    April 2024
74. WAI KM, Mishra K, Koo E, Ludwig CA, et al
    Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
    Am J Ophthalmol. 2024 Apr 16:S0002-9394(24)00150.
    

    >> Share

    
    March 2024
75. JOSEPH S, Selvaraj J, Mani I, Kumaragurupari T, et al
    Diagnostic accuracy of artificial intelligence based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.
    Am J Ophthalmol. 2024 Mar 2:S0002-9394(24)00066.
    

    >> Share

    
    February 2024
76. DAI Y, Zheng D, Zhao J, Wang K, et al
    Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study.
    Am J Ophthalmol. 2024 Feb 28:S0002-9394(24)00090.
    

    >> Share

    
    November 2023
77. DANZINGER V, Schartmuller D, Lisy M, Schranz M, et al
    Intraindividual Comparison Of An Enhanced Monofocal And An Aspheric Monofocal Intraocular Lens Of The Same Platform.
    Am J Ophthalmol. 2023 Nov 7:S0002-9394(23)00463.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share